RecruitingPhase 1Phase 2NCT05621889

Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer

Impacts of an Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model to Prevent Swallowing Disorders in Patients Treated With Chemoradiotherapy for Head and Neck Cancer

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

76 participants

Start Date

Jun 2, 2023

Study Type

INTERVENTIONAL

Conditions

Dysphagia

Summary

This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer. The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a virtual (online), patient-partnered group speech therapy program can help people with head and neck cancer maintain their ability to swallow and communicate during and after chemoradiotherapy treatment. **You may be eligible if...** - You are 18 or older and have been diagnosed with head or neck cancer - You are scheduled to receive chemoradiotherapy with the goal of curing your cancer - Your planned radiation dose is at least 60 Grays (a standard curative dose) - You have sufficient French language ability to complete questionnaires **You may NOT be eligible if...** - Your cancer has spread to distant organs (metastases) - You are planned to have a total removal of your voice box (laryngectomy) - You already have moderate to severe swallowing difficulties - You have a second cancer diagnosed at the same time - You have previously had radiation therapy to the head or neck area - You have a cognitive impairment that would significantly interfere with participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.